JAKAFI (Ruxolitinib) Emerging Drug Insights and Market Forecasts, 2019-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
January 24, 2024 07:57 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "JAKAFI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
China Ruxolitinib Market Report 2021-2025: An Orally Bioavailable Janus-associated kinase (JAK) Inhibitor with Selectivity for Subtypes JAK1 and JAK2
June 18, 2021 07:53 ET
|
Research and Markets
Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Ruxolitinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Ruxolitinib was developed by...